Glioblastoma Microenvironment and Cellular Interactions.
cellular interactions
glioblastoma
microenvironment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Feb 2022
21 Feb 2022
Historique:
received:
05
01
2022
revised:
31
01
2022
accepted:
16
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
The central nervous system (CNS) represents a complex network of different cells, such as neurons, glial cells, and blood vessels. In tumor pathology, glial cells result in the highest number of cancers, and glioblastoma (GB) is considered the most lethal tumor in this region. The development of GB leads to the infiltration of healthy tissue through the interaction between all the elements of the brain network. This results in a GB microenvironment, a complex peritumoral hallo composed of tumor cells and several non-tumor cells (e.g., nervous cells, stem cells, fibroblasts, vascular and immune cells), which might be the principal factor for the ineffective treatment due to the fact that the microenvironment modulates the biologic status of the tumor with the increase in its evasion capacity. Crosstalk between glioma cells and the brain microenvironment finally inhibits the beneficial action of molecular pathways, favoring the development and invasion of the tumor and its increasing resistance to treatment. A deeper understanding of cell-cell interactions in the tumor microenvironment (TME) and with the tumor cells could be the basis for a more efficient therapy.
Identifiants
pubmed: 35205842
pii: cancers14041092
doi: 10.3390/cancers14041092
pmc: PMC8870579
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Front Cell Dev Biol. 2021 Mar 01;9:641469
pubmed: 33732706
Neuro Oncol. 2016 Dec;18(12):1622-1633
pubmed: 27298311
Glia. 2009 Oct;57(13):1458-67
pubmed: 19306372
Cancers (Basel). 2020 Apr 01;12(4):
pubmed: 32244839
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
J Immunol. 2012 Jul 1;189(1):444-53
pubmed: 22664874
Neurosci Lett. 2017 Apr 3;645:106-112
pubmed: 28259657
Nat Commun. 2021 Nov 26;12(1):6938
pubmed: 34836966
Biochem J. 2000 Jul 1;349(Pt 1):159-67
pubmed: 10861224
Cancer Med. 2015 Nov;4(11):1705-16
pubmed: 26518290
Am J Pathol. 2012 May;180(5):2108-19
pubmed: 22440258
Oncol Rep. 2010 Jun;23(6):1553-9
pubmed: 20428809
Clin Neurol Neurosurg. 2004 Dec;107(1):49-54
pubmed: 15567553
Nat Med. 2002 Sep;8(9):971-8
pubmed: 12172541
Int J Mol Sci. 2020 Mar 13;21(6):
pubmed: 32182988
PLoS One. 2010 Oct 27;5(10):e13665
pubmed: 21060868
Neurosignals. 2008;16(2-3):154-64
pubmed: 18253055
Trends Neurosci. 1993 May;16(5):186-92
pubmed: 7685944
Physiol Rev. 2018 Jan 1;98(1):239-389
pubmed: 29351512
Glia. 2018 Jun;66(6):1213-1234
pubmed: 29098734
Brain Res Brain Res Rev. 2000 Apr;32(2-3):380-412
pubmed: 10760549
Neuro Oncol. 2012 Nov;14(11):1379-92
pubmed: 22965162
Brain Tumor Pathol. 2012 Apr;29(2):87-95
pubmed: 22076316
Clin Cancer Res. 2018 Sep 1;24(17):4175-4186
pubmed: 29437767
Brain Pathol. 2017 Jan;27(1):36-50
pubmed: 26762242
Clin Cancer Res. 2015 Oct 15;21(20):4630-41
pubmed: 26106074
Mol Neurobiol. 2018 Aug;55(8):6927-6938
pubmed: 29363044
Neuro Oncol. 2015 Mar;17(3):343-60
pubmed: 25253418
Cancers (Basel). 2019 Jun 20;11(6):
pubmed: 31226836
Cancer Res. 2003 Oct 15;63(20):6613-25
pubmed: 14583454
Neurol Med Chir (Tokyo). 2018 Feb 15;58(2):61-70
pubmed: 29129882
Front Mol Biosci. 2021 May 17;8:669366
pubmed: 34079819
J Transl Med. 2021 Dec 24;19(1):529
pubmed: 34952595
Natl Sci Rev. 2020 Aug;7(8):1306-1318
pubmed: 34692159
Front Immunol. 2021 Aug 13;12:701383
pubmed: 34484197
Cells. 2020 May 13;9(5):
pubmed: 32413966
Acta Neuropathol Commun. 2021 Mar 25;9(1):54
pubmed: 33766119
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
PLoS One. 2012;7(2):e32453
pubmed: 22393407
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Oncotarget. 2017 May 30;8(22):36137-36148
pubmed: 28410224
Cell Mol Life Sci. 2014 Feb;71(4):575-97
pubmed: 23771628
Glia. 2018 Jun;66(6):1200-1212
pubmed: 29219210
Cancer Cell. 2012 Jul 10;22(1):21-35
pubmed: 22789536
Science. 2017 Mar 31;355(6332):
pubmed: 28360267
Curr Biol. 2007 Jan 23;17(2):165-72
pubmed: 17196391
Genes (Basel). 2021 Mar 20;12(3):
pubmed: 33804731
Exp Cell Res. 2017 Nov 15;360(2):66-73
pubmed: 28782555
Gigascience. 2020 Oct 14;9(10):
pubmed: 33155039
Nat Commun. 2021 Feb 19;12(1):1151
pubmed: 33608526
F1000Prime Rep. 2014 Mar 03;6:13
pubmed: 24669294
Stem Cells Int. 2019 Jun 18;2019:6107456
pubmed: 31316566
Oncogene. 2016 Mar 24;35(12):1504-16
pubmed: 26165844
Front Oncol. 2021 Feb 24;11:615704
pubmed: 33718170
Nat Cell Biol. 2015 Dec;17(12):1556-68
pubmed: 26595383
J Neuropathol Exp Neurol. 2005 Sep;64(9):754-62
pubmed: 16141784
Trends Cancer. 2020 Mar;6(3):223-235
pubmed: 32101725
Am J Pathol. 2013 Jun;182(6):2368-79
pubmed: 23583652
Mol Cancer. 2017 Feb 16;16(1):41
pubmed: 28209166
Neurosurg Focus. 2014 Dec;37(6):E6
pubmed: 25434391
Biomed Pharmacother. 2019 Jan;109:39-46
pubmed: 30391707
Int J Neurosci. 2013 May;123(5):318-23
pubmed: 23240619
Biomed Pharmacother. 2020 Jun;126:110086
pubmed: 32172060
J Immunol. 2010 Aug 1;185(3):1450-9
pubmed: 20622113
Brain. 2013 Mar;136(Pt 3):828-43
pubmed: 23364351
Clin Exp Metastasis. 2011 Jan;28(1):13-25
pubmed: 20953899
Oncotarget. 2021 Aug 17;12(17):1707-1723
pubmed: 34434499
Front Cell Neurosci. 2013 Oct 11;7:179
pubmed: 24130515
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
Oncotarget. 2019 May 3;10(33):3129-3143
pubmed: 31139325
Neuron. 2019 Nov 6;104(3):442-449
pubmed: 31697921
Front Oncol. 2021 Jan 26;10:614930
pubmed: 33575218
Front Oncol. 2019 Nov 15;9:1146
pubmed: 31799175
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Nat Rev Neurol. 2015 Jan;11(1):56-64
pubmed: 25385337
Nat Commun. 2020 Oct 27;11(1):5424
pubmed: 33110073
J Biol Chem. 2007 Jul 20;282(29):21206-12
pubmed: 17513297
Oncol Rep. 2009 Dec;22(6):1349-56
pubmed: 19885586
Biochem J. 2021 Jan 15;478(1):21-39
pubmed: 33245115
Nat Cell Biol. 2015 Feb;17(2):170-82
pubmed: 25580734
J Neurodegener Dis. 2014;2014:369468
pubmed: 26317008
IEEE Trans Biomed Eng. 2017 Mar;64(3):519-527
pubmed: 27959794
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Front Oncol. 2017 Jul 05;7:144
pubmed: 28730141
Front Immunol. 2018 May 08;9:1004
pubmed: 29867979
J Natl Cancer Inst. 2014 Jun 28;106(8):
pubmed: 24974128
Front Immunol. 2017 Aug 04;8:930
pubmed: 28824650
Stem Cells Int. 2016;2016:6809105
pubmed: 26880981
Life Sci. 2019 Oct 1;234:116781
pubmed: 31430455
Cancer Res. 1999 Apr 15;59(8):1994-2003
pubmed: 10213512
Annu Rev Immunol. 2021 Apr 26;39:131-166
pubmed: 33481643
Cancer Immunol Res. 2017 Dec;5(12):1098-1108
pubmed: 29070650
Oncotarget. 2018 Oct 19;9(82):35287-35288
pubmed: 30450155
Nat Neurosci. 2017 Mar;20(3):396-405
pubmed: 28166219
Lab Invest. 2020 Apr;100(4):619-629
pubmed: 31748682
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Mol Neurobiol. 2019 Jun;56(6):4566-4581
pubmed: 30353492
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7
pubmed: 23589885
Oncol Lett. 2016 Mar;11(3):1615-1620
pubmed: 26998052
iScience. 2018 Nov 30;9:71-83
pubmed: 30384135
Biomedicines. 2021 Sep 26;9(10):
pubmed: 34680444
Glia. 2011 Mar;59(3):472-85
pubmed: 21264953
Cancer Lett. 2014 Oct 28;353(2):194-200
pubmed: 25079688
Cancer Cell. 2007 Jan;11(1):69-82
pubmed: 17222791
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Front Cell Neurosci. 2018 Aug 03;12:235
pubmed: 30123112
J Clin Invest. 2017 Aug 1;127(8):3136-3151
pubmed: 28737509
Int J Biochem Cell Biol. 2009 Feb;41(2):349-69
pubmed: 18848899
Front Immunol. 2019 Jul 03;10:1515
pubmed: 31354705
Nat Rev Cancer. 2006 Jul;6(7):506-20
pubmed: 16794634
Immunobiology. 2020 Jan;225(1):151853
pubmed: 31703822
Biomaterials. 2018 Apr;161:164-178
pubmed: 29421553
Biochim Biophys Acta Mol Cell Res. 2020 Oct;1867(10):118782
pubmed: 32554164
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
Mol Cancer. 2017 Aug 15;16(1):137
pubmed: 28810877
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
BMB Rep. 2017 Mar;50(3):117-125
pubmed: 27998397
Glia. 2001 Feb;33(2):107-17
pubmed: 11180508
Genes Dev. 2008 Aug 1;22(15):1987-97
pubmed: 18676805
Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3207-3211
pubmed: 28770964
J Neurophysiol. 2001 Feb;85(2):790-803
pubmed: 11160513
Cancer Immunol Res. 2014 Dec;2(12):1199-208
pubmed: 25300859
Cell Signal. 2006 May;18(5):592-600
pubmed: 16183253
Front Oncol. 2018 Dec 21;8:646
pubmed: 30622930
Crit Rev Oncol Hematol. 2008 Apr;66(1):1-9
pubmed: 17913510
Indian J Surg Oncol. 2015 Dec;6(4):400-14
pubmed: 27081258
ISRN Neurol. 2011;2011:590249
pubmed: 22389824
Front Immunol. 2021 Nov 02;12:770390
pubmed: 34795675
Nature. 2015 Dec 3;528(7580):93-8
pubmed: 26536111
Front Oncol. 2019 Mar 06;9:118
pubmed: 30895167
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Cell Oncol (Dordr). 2017 Oct;40(5):471-482
pubmed: 28643230
Cancers (Basel). 2019 Apr 15;11(4):
pubmed: 30991681
Nature. 2010 Dec 9;468(7325):824-8
pubmed: 21102434
Bioessays. 2011 May;33(5):319-26
pubmed: 21337590
Nat Rev Neurosci. 2011 Feb;12(2):88-104
pubmed: 21248788
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45):
pubmed: 34740973
Immunity. 2017 Jun 20;46(6):957-967
pubmed: 28636962
J Neurooncol. 2014 Jan;116(1):1-9
pubmed: 24085644
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389898
J Clin Invest. 2019 Jan 2;129(1):137-149
pubmed: 30307407
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13147-52
pubmed: 21788507
Mol Cancer. 2018 Aug 31;17(1):132
pubmed: 30165850
Trends Neurosci. 2009 Dec;32(12):638-47
pubmed: 19782411
Neurooncol Adv. 2020 May 06;2(1):vdaa056
pubmed: 32642708
Ann N Y Acad Sci. 2002 Nov;973:60-9
pubmed: 12485835
Expert Rev Neurother. 2015;15(7):741-52
pubmed: 26027432
Sci Rep. 2018 Jul 11;8(1):10426
pubmed: 29993014
Front Endocrinol (Lausanne). 2021 Feb 18;12:626390
pubmed: 33679620
Oncogenesis. 2014 Oct 20;3:e123
pubmed: 25329722
J Neurochem. 1999 Oct;73(4):1674-82
pubmed: 10501215
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):997-1006
pubmed: 30602457
Int J Mol Sci. 2020 Jun 02;21(11):
pubmed: 32498400
Neuromolecular Med. 2015 Dec;17(4):335-52
pubmed: 26224516
Oncotarget. 2016 Nov 1;7(44):71673-71685
pubmed: 27765933
Anal Cell Pathol (Amst). 2020 Jan 8;2020:6283796
pubmed: 32377504
J Neuroinflammation. 2017 Nov 13;14(1):220
pubmed: 29132376
Cell Mol Immunol. 2020 Sep;17(9):925-939
pubmed: 32699351
Int J Mol Sci. 2020 Jan 21;21(3):
pubmed: 31973030
Front Pharmacol. 2020 Apr 08;11:368
pubmed: 32322199
Nat Cell Biol. 2000 Feb;2(2):76-83
pubmed: 10655586
Mol Med Rep. 2016 Feb;13(2):1329-35
pubmed: 26676970
Nat Neurosci. 2004 Nov;7(11):1233-41
pubmed: 15494728
J Biol Chem. 1998 Apr 10;273(15):9188-96
pubmed: 9535909
Cells. 2019 Nov 06;8(11):
pubmed: 31698775
Nat Rev Genet. 2006 Jan;7(1):21-33
pubmed: 16369569
Br J Cancer. 2014 Feb 4;110(3):724-32
pubmed: 24335925
Int J Mol Sci. 2022 Jan 06;23(2):
pubmed: 35054779
Biomed Res Int. 2017;2017:9634172
pubmed: 28630875
Cancer Lett. 2012 Dec 1;325(1):42-53
pubmed: 22652173
Expert Rev Mol Diagn. 2012 May;12(4):383-94
pubmed: 22616703
Cell Adh Migr. 2017 Mar 4;11(2):164-172
pubmed: 27736300
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
PLoS One. 2016 Apr 19;11(4):e0153550
pubmed: 27092773
Oncoimmunology. 2015 Jun 5;5(1):e1056442
pubmed: 26942063
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3581-6
pubmed: 18299565
Trends Cancer. 2018 Nov;4(11):784-792
pubmed: 30352680
Cancer Immunol Immunother. 2018 Oct;67(10):1545-1558
pubmed: 30054667
J Oncol. 2012;2012:376894
pubmed: 22685459
Cells. 2020 Dec 24;10(1):
pubmed: 33374253
Med Sci Monit. 2018 Mar 27;24:1784-1792
pubmed: 29582851
Mol Cancer. 2019 Mar 30;18(1):59
pubmed: 30925927
Front Cell Dev Biol. 2021 Jun 11;9:693215
pubmed: 34211978
Neurochem Int. 2019 Jan;122:139-143
pubmed: 30496766
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21659-64
pubmed: 21118979
Brain Behav Immun. 2011 May;25(4):624-8
pubmed: 21324352
J Clin Invest. 2018 Dec 3;128(12):5322-5334
pubmed: 30226829
Exp Hematol Oncol. 2022 Jan 24;11(1):3
pubmed: 35074008
Br J Cancer. 2005 Oct 3;93(7):781-92
pubmed: 16175187
Neuro Oncol. 2017 Oct 19;19(11):1435-1446
pubmed: 28575312
Int J Mol Sci. 2021 Jun 17;22(12):
pubmed: 34204510
J Neurosci. 2003 May 15;23(10):4034-43
pubmed: 12764090
Differentiation. 2013 Oct;86(3):126-32
pubmed: 23660532
J Hematol Oncol. 2021 Jun 12;14(1):92
pubmed: 34118979
J Cell Biol. 2006 Mar 27;172(7):973-81
pubmed: 16567498
Neuroscience. 2004;128(4):775-83
pubmed: 15464285
Front Oncol. 2020 Dec 07;10:580263
pubmed: 33425732
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Cell Res. 2012 Mar;22(3):457-72
pubmed: 22357481
Cancer Lett. 2015 Jan 28;356(2 Pt A):289-300
pubmed: 25069036
Cancer Lett. 2021 Oct 1;517:35-45
pubmed: 34098063
Arch Biochem Biophys. 2012 Aug 1;524(1):2-15
pubmed: 22430362
Mol Neurobiol. 2016 Dec;53(10):7184-7199
pubmed: 26687184
PLoS One. 2021 Feb 5;16(2):e0246646
pubmed: 33544755
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819869949
pubmed: 31451090
J Cell Sci. 2012 Feb 15;125(Pt 4):844-57
pubmed: 22275437
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
Cancers (Basel). 2018 Dec 20;11(1):
pubmed: 30577488
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Cell Mol Life Sci. 2019 Oct;76(20):4043-4070
pubmed: 31317205
J Clin Med. 2021 Mar 26;10(7):
pubmed: 33810532
Nature. 2016 May 18;533(7604):493-498
pubmed: 27225120
Genes Dev. 2019 Jun 1;33(11-12):591-609
pubmed: 31160393
Cancer Res. 2014 Feb 1;74(3):738-750
pubmed: 24310399
Cell Death Discov. 2018 Dec 5;4:110
pubmed: 30534418
Nature. 2018 Aug;560(7717):243-247
pubmed: 30069053
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Int J Mol Sci. 2020 Dec 27;22(1):
pubmed: 33375505
Cancer Cell. 2021 Jun 14;39(6):779-792.e11
pubmed: 34087162
Oncogene. 2016 Dec 15;35(50):6366-6377
pubmed: 27041573
Front Oncol. 2019 Apr 30;9:327
pubmed: 31114757
J Radiat Res. 2010;51(3):343-8
pubmed: 20410674
Cell Rep. 2021 Aug 3;36(5):109480
pubmed: 34348160
J Biol Chem. 2002 Sep 27;277(39):36725-30
pubmed: 12119284
Biomark Med. 2021 Aug;15(11):851-859
pubmed: 33983042
EMBO Mol Med. 2013 Aug;5(8):1196-212
pubmed: 23818228
Sci Rep. 2021 Oct 26;11(1):21133
pubmed: 34702850
J Neurooncol. 2004 Oct;70(1):3-15
pubmed: 15527101
Stem Cell Res Ther. 2021 Mar 24;12(1):206
pubmed: 33762015
Oncogene. 2016 May 19;35(20):2615-23
pubmed: 26364614
Glia. 2020 Feb;68(2):316-327
pubmed: 31509308
Glia. 2018 Jan;66(1):161-174
pubmed: 28948650
Cell. 2015 May 7;161(4):803-16
pubmed: 25913192
Sci Adv. 2018 Mar 07;4(3):eaar2766
pubmed: 29532035
Signal Transduct Target Ther. 2021 Mar 23;6(1):124
pubmed: 33753720
Nat Neurosci. 2016 Jan;19(1):20-7
pubmed: 26713745
J Neuropathol Exp Neurol. 1998 Dec;57(12):1112-21
pubmed: 9862633
J Neurosci. 2016 Jul 6;36(27):7109-27
pubmed: 27383588
J Immunol. 2004 Jan 1;172(1):464-74
pubmed: 14688356
Biomolecules. 2017 Mar 27;7(2):
pubmed: 28346397
Neuro Oncol. 2017 Oct 1;19(10):1316-1326
pubmed: 28419303
Sci Rep. 2020 Nov 11;10(1):19542
pubmed: 33177572
Mol Cancer. 2011 Feb 11;10:17
pubmed: 21314958
J Extracell Vesicles. 2017 Aug 8;6(1):1359479
pubmed: 28815003
Front Cell Neurosci. 2021 Oct 06;15:709917
pubmed: 34690699
Int J Mol Sci. 2021 Mar 24;22(7):
pubmed: 33804873
Front Mol Neurosci. 2019 Mar 19;12:63
pubmed: 30949026
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Nat Cell Biol. 2019 Jan;21(1):102-112
pubmed: 30602760
Cancer Res. 1990 Sep 15;50(18):6039-44
pubmed: 2393868
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Brain Commun. 2019 Dec 04;2(1):fcz043
pubmed: 32954312
Cancers (Basel). 2022 Jan 21;14(3):
pubmed: 35158807
Cell. 2020 Jun 25;181(7):1626-1642.e20
pubmed: 32470397
Front Oncol. 2018 Oct 23;8:462
pubmed: 30406029
Oncotarget. 2015 Jun 20;6(17):15566-77
pubmed: 25978028
Oncotarget. 2016 Nov 8;7(45):73414-73431
pubmed: 27705917
Cancer Res. 2011 Mar 1;71(5):1550-60
pubmed: 21343399
Int J Mol Sci. 2016 Dec 13;17(12):
pubmed: 27983603
BMC Cancer. 2017 Aug 29;17(1):583
pubmed: 28851312
Front Pharmacol. 2017 Jan 04;7:521
pubmed: 28101056
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
J Neurosci. 2013 Sep 25;33(39):15603-17
pubmed: 24068827
Neurochem Int. 2017 Sep;108:100-108
pubmed: 28279751
Nat Med. 2018 Sep;24(9):1459-1468
pubmed: 30104766
Cell Rep. 2019 Dec 10;29(11):3460-3471.e7
pubmed: 31825829
Nat Commun. 2019 Jun 11;10(1):2541
pubmed: 31186414
Med Res Rev. 2017 Mar;37(2):271-313
pubmed: 27617697
Tumour Biol. 2016 Jan;37(1):61-9
pubmed: 26493995
Cancer Res. 2011 Mar 1;71(5):1647-57
pubmed: 21239473
Genes Dev. 2015 Jun 15;29(12):1203-17
pubmed: 26109046
Front Oncol. 2021 Jul 08;11:701291
pubmed: 34307170
Int J Cancer. 2015 Sep 1;137(5):1012-20
pubmed: 25487790
Front Endocrinol (Lausanne). 2017 Aug 08;8:194
pubmed: 28848498